Ep 73 is a panel interview — "View" is the conversation's net read on each name; the speaker who made the argument (Trennert, Verrone, or Eisman) is named in "What he said." The three ad reads (Long Angle, Qwoka, DripDrop) are advertising, not picks, and are excluded. Research: QT Qualtrim · SA Seeking Alpha · STK Stock Analysis.
| Ticker | Name | Research | View | What he said | At |
|---|---|---|---|---|---|
| PWR | Quanta Services | QT · SA · STK · FA | Positive | Verrone's lead example of the AI build-out names that already took their correction and are working again: "after deep corrections in what I would call AI-adjacent or build-out type names, Quanta, Emcore… these probably down 30% from the highs… They've all responded over the last couple weeks." Eisman adds the print: "Quanta was up like 15% on earnings day last week. It was amazing." The discipline attached: "you have to give these the benefit of the doubt until they attempt to rally, don't make new highs, and fail. And we haven't seen that yet." | 25:29 |
| EME | EMCOR Group | QT · SA · STK · FA | Positive | Verrone names it beside Quanta as an "AI-adjacent or build-out type name" down ~30% from the highs that has since responded (the auto-caption renders it "Emcore" — the peer set is data-center construction contractors, i.e. EMCOR Group, not the photonics microcap). Same rule applies: give it the benefit of the doubt until a rally fails to make a new high. | 25:29 |
| CAT | Caterpillar | QT · SA · STK · FA | Positive | Verrone: "Caterpillar had a pretty big quarter" — the third of the build-out names that corrected deeply and "all responded over the last couple weeks." Consistent with Eisman's own May 1 read of CAT as an AI story via data-center construction equipment. | 25:29 |
| STT | State Street | QT · SA · STK · FA | Positive | Verrone's evidence for the "alpha market": "you're seeing all these asset managers start to break out here for the first time in years… everything from State Street to T. Rowe to Invesco… that's really been the leadership in the asset management space." The active-vs-passive read: they "have been on the wrong side of the passive trade for the better part of the last 15 years in this QE environment," and the tape is now saying that regime is turning. | 12:22 |
| TROW | T. Rowe Price Group | QT · SA · STK · FA | Positive | Named in the same breakout list — Eisman asks whether "traditional money management stocks [are] outperforming PE stocks" and Verrone answers with the group: "everything from State Street to T. Rowe to Invesco." The active manager is the direct beneficiary if stock picking matters again. | 12:22 |
| IVZ | Invesco | QT · SA · STK · FA | Positive | The third name in Verrone's asset-manager breakout list, cited as leadership within the sector for the first time in years — the tape's message that "stock picking and active matters a lot more than passive." | 12:22 |
| BEN | Franklin Resources | QT · SA · STK · FA | Positive | "Ben's been a great chart" — Verrone, immediately after listing State Street, T. Rowe and Invesco as the asset-management leadership. Read with care: the auto-caption gives only "Ben"; inside a list of traditional asset managers it reads as Franklin Resources (NYSE: BEN), which is how it is tickerized here, but the transcript does not say the company name. | 12:22 |
| MS | Morgan Stanley | QT · SA · STK · FA | Positive | Verrone: "The brokers have been excellent here. We've all seen Morgan Stanley and Goldman Sachs, but even some of the smaller ones, they are still leadership" — inside a global bank tape where "every bank stock around the world is at new highs," public credit is "very benign" and double-B spreads made new cycle lows. Trennert's fundamental version: the curve steepens, "the economy is strong, so… the credit losses should be pretty minimal," and Strategas' Dan Clifton's call that this is "an extreme period of financial deregulation." | 32:32 |
| GS | Goldman Sachs | QT · SA · STK · FA | Positive | Named with Morgan Stanley by Verrone as the excellent brokers inside a leadership group that is global — "Japanese banks, even with yen intervention and JGB yield… continue to lead. European banks have been absolutely exceptional." His discomfort is the flip side of the same fact: "I just can't think of too many times in my career… where you're on the verge of a big problem and every bank stock around the world is at new highs. It seems a little out of step." | 32:32 |
| TMO | Thermo Fisher Scientific | QT · SA · STK · FA | Positive | Verrone's highest-conviction defensive call: "pharma and biotech and life sciences have been leadership. They remain the leadership. They act great. I think these reversals in some of these left for dead life science stocks are particularly notable. The thermos and the Danaher's and the Illumina's, which haven't been looked at in years — I think they put in major major bottoms." Health care "comes at the top of that pile" of defensives. | 40:50 |
| DHR | Danaher | QT · SA · STK · FA | Positive | The second of Verrone's three "left for dead" life-science reversals that "haven't been looked at in years" and have, on his read of the charts, "put in major major bottoms" — part of the health-care complex he ranks at the top of the defensive sectors. | 40:50 |
| ILMN | Illumina | QT · SA · STK · FA | Positive | The third "left for dead" life-science name in Verrone's bottoming list, cited for exactly the reason it is interesting — nobody has looked at it in years, and the reversal is "particularly notable." | 40:50 |
| UNH | UnitedHealth Group | QT · SA · STK · FA | Positive | Asked about health insurance, Verrone concedes a miss: "these put major lows in. I missed it. They put major lows in late last year early this year. The UNH's of the world, the Signas. I got too dogmatic on those and I missed it. We try not to do that." Constructive on the group, but he says the leadership right now is pharma and biotech rather than managed care. Trennert's caveat: populist politics runs against "big anything," and government's expanding role that "worked for them for many years" now works the other way on pricing. | 41:07 |
| CI | Cigna Group | QT · SA · STK · FA | Positive | Named with UnitedHealth ("the Signas") as the managed-care names that "put major lows in late last year early this year" — the move Verrone says he missed by being "too dogmatic." Bottomed, but behind pharma/biotech in his leadership ranking. | 41:07 |
| KHC | Kraft Heinz | QT · SA · STK · FA | Positive | The one flicker in the worst defensive group. Eisman: "There's… where is the life?" Verrone: "Kraft Heinz, Hershey's all starting to bottom here. I think they're worth a look" — after "a just devastatingly bad couple years." He is careful to size the call: "I would hardly call the sector leader in the market," and staples stay "probably still near the bottom" of his defensive ranking. | 40:31 |
| HSY | Hershey | QT · SA · STK · FA | Positive | Named beside Kraft Heinz as the staples "all starting to bottom here… worth a look" (Verrone) — a bottoming call inside a group he still ranks last among defensives, not a leadership call. | 40:31 |
| SU.PA | Schneider Electric | QT · SA · STK | Positive | Verrone, asked what has actually carried the Euro Stoxx to a new high while European autos and luxury sit in multi-year bear markets: "It's been stocks like Schneider Electric — AI buildout." The point cuts against owning Europe as a diversifier: the index's new high is the same AI-build-out theme as the US, plus banks, not a broad European recovery. | 37:21 |
| ENR.DE | Siemens Energy | QT · SA · STK | Positive | The second name Verrone credits for Europe's new high: "It's been names like Siemens Energy turbines." Same read as Eisman's own GE Vernova thesis — sell the power equipment into the AI build-out rather than owning the spender. | 37:21 |
| AMZN | Amazon | QT · SA · STK · FA | Positive | Both halves of the argument land on it. Trennert's client: "I've never heard a more bullish conference call in my life than Amazon last night" — "and it's true, but I don't see how you do it without hitting the bond and equity markets… it's not going to come out of cash flow" (Amazon's cash flow "was negative for the 12 months"). Verrone's tape: "Amazon just made new highs," part of the two-to-three-week momentum in the hyperscalers that makes them "at a minimum… tradeable." Also Trennert's example of the tech-adjacent name that pushes S&P tech-plus-tech-adjacent weight "over 50%." | 21:26 |
| MSFT | Microsoft | QT · SA · STK · FA | Positive | The best of a deteriorating set on Eisman's numbers — "Microsoft's, which was the best of anybody, was about 19 billion [of quarterly cash flow] but it was down around 25% versus last year" — and the strongest tape on Verrone's: "The 5-day change in Microsoft is the best we've seen since the IPO in '87," evidence that the negativity of two-to-three weeks earlier had gone too far. Also the historical template for the antitrust segment ("Microsoft in the '90s, very similar story" to IBM). | 23:18 |
| GOOGL | Alphabet (Google) | QT · SA · STK · FA | Neutral | The name that got Strategas fired. Trennert's "anodyne sentence" — "it's going to be hard to continue to grow AI investments without further dilution of shareholders" — was written "mainly cuz you saw Google issue 85 billion dollars in equity," and he calls the raise "shocking given the fact that the last time they actually raised equity capital was in the 2000s." Against that, Verrone's tape: "Google's basically back at the highs here." Net: dilution is the structural worry, momentum is the near-term fact — and Trennert explicitly "wouldn't short it." | 21:50 |
| ORCL | Oracle | QT · SA · STK · FA | Neutral | Two roles, pulling opposite ways. Trennert uses it as evidence for the dilution thesis: "all the hyperscalers are issuing debt now. Oracle was just downgraded." Verrone uses it as the sentiment marker instead — the attitudes toward the hyperscalers "reached a fever pitch of negativity maybe two or three weeks ago… When Oracle got to like 120" — i.e. the low print is the emotional extreme, not the fundamental verdict. | 22:33 |
| CSCO | Cisco Systems | QT · SA · STK · FA | Neutral | Historical reference only. Verrone: "go back to '99 or 2000. If I told you the leading stocks, Cisco or Sun Micro, were going to be down 40 or 50% over an 8-week period, what do you think the S&P or the Nasdaq would be down? A lot." The point is about 2026's resilience, not about Cisco. | 7:37 |
| IBM | International Business Machines | QT · SA · STK · FA | Neutral | The case study behind the regulatory-risk segment, not a rating. Trennert: the 1970s antitrust suit "lasted 12 years. IBM won, quote unquote, but they really lost because it consumes so much of their time and effort that they missed personal computing." Eisman supplies Judge Richard Posner's verdict — "the lawsuit was the punishment… didn't have to win" — plus the discovery story of ten trucks of uncorrelated boxes that added two more years. | 29:27 |
| META | Meta Platforms | QT · SA · STK · FA | Negative | Eisman's name — "let's look at one that maybe you don't have to give the benefit of the doubt to." He went over the numbers himself: "the revenue grew 28%… and the expenses grew 55%… we want the reverse," with "no indication that that's going to change anytime soon," quarterly cash flow of only $785M, and "the depreciation is starting to really explode… from like 4 billion to 6 billion, it'll go to 8, then 10, then 12. It's like a weight on your shoulders." Plus the legal overhang — "hundreds" of social-media suits, two decided against it, and the IBM/Microsoft lesson that the distraction is the damage. Verrone is neutral and respects only the tape: down 10-12% after earnings and "3 days later it's recovered the entire loss… I have to respect a move like that." | 28:28 |
| Anthropic | Anthropic (private) | — | Negative | Trennert separates the layers exactly as Eisman does: "you could argue the hyperscalers have a real business and they're real moats around it, but it's a lot more capital intensive. The Anthropic's or Open AI's of the world, that's where it's most questionable… they're totally negative cash flow," and "the Chinese are competing with them." Then the systemic number: "something like 70% of the AI hyperscaler revenue is from just those two companies. So if this is the big if, if Open AI and Anthropic ever get in trouble, the ecosystem is in trouble." Eisman: "I think it's undeniable." | 24:15 |
| OpenAI | OpenAI (private) | — | Negative | The other half of the same dependency. Trennert: "totally negative cash flow," Chinese competition, and together with Anthropic roughly 70% of hyperscaler AI revenue — "if Open AI and Anthropic ever get in trouble, the ecosystem is in trouble." Independent confirmation of the map Eisman laid out solo on the Aug 14 wrap. | 24:15 |
| CEG | Constellation Energy | QT · SA · STK · FA | Negative | The episode's most surprising negative. Verrone: regulated utilities "have traded poorly all year… as a group they're making new lows here. The unregulated ones, the more power producers, the CEGs and the Talons and the Vistra's have also started to weaken here." The diagnosis is political, not fundamental: "the politics are starting to consume the utility sector… cuz the unregulated [names] what you would expect to be great in this environment are really starting to weaken." | 39:57 |
| TLN | Talen Energy | QT · SA · STK · FA | Negative | Named with Constellation and Vistra ("the Talons") among the unregulated power producers that "have also started to weaken here" despite an environment you would expect to be ideal for them — the tell Verrone reads as politics consuming the utility sector. | 39:57 |
| VST | Vistra | QT · SA · STK · FA | Negative | The third unregulated power producer Verrone flags as weakening alongside Constellation and Talen — the AI-power trade breaking down at the generator level even while the AI build-out contractors (Quanta, EMCOR, Caterpillar) are working. | 39:57 |
"View" is the conversation's net read in this episode (Positive / Neutral / Negative), not a price rating. Through-line: a threshold, not a forecast — the AI leaders already fell 30-50% from mid-May while the index's internals improved (50% → 75% above the 200-day), so the cycle ends only when a rate finally competes with equities, and that level is "much higher than people think." Leadership is where the AI capex actually lands (PWR, EME, CAT, SU.PA, ENR.DE), where deregulation lands (MS, GS), and where an "alpha market" would land (STT, TROW, IVZ, BEN); the risk is dilution at the spenders (GOOGL, ORCL, META) and the two negative-cash-flow labs (Anthropic, OpenAI) underneath 70% of hyperscaler AI revenue. Defensives rank health care first (TMO, DHR, ILMN, UNH, CI), staples last-but-bottoming (KHC, HSY), and utilities as an outright avoid (CEG, TLN, VST). Research: QT Qualtrim · SA Seeking Alpha · STK Stock Analysis.
What each name actually is, and why it came up — jargon translated, stance stated in ordinary language.
Quanta is the contractor that physically builds and maintains electricity infrastructure — transmission lines, substations, the grid connections a data centre needs before it can draw power. It doesn't own the AI story; it gets paid to install it.
Verrone's point is about sequence, not fundamentals. This kind of "AI-adjacent build-out" name fell roughly 30% from its highs during the mid-May-to-August correction, and has since started working again — Quanta jumped about 15% on its earnings day. His rule for what to do next is refreshingly falsifiable: keep giving the group the benefit of the doubt until it tries to rally, fails to reach a new high, and rolls over. That hasn't happened, so the position stays.
EMCOR is the mechanical and electrical construction firm on the other side of the same trade — the people who install the power, cooling and piping systems inside large buildings, data centres very much included. Named in the same breath as Quanta, for the same reason: a deep correction that has since been repaired.
One caution worth recording: the auto-transcript renders it "Emcore," which is a different and much smaller photonics company. The context — a peer of Quanta, a build-out contractor down 30% — makes EMCOR the intended name.
Caterpillar sells the earth-moving and power-generation equipment that data-centre construction consumes, which is why a heavy-machinery company now trades partly as an AI name. Verrone notes it "had a pretty big quarter" and, like Quanta and EMCOR, has responded after a deep decline.
This is the same "own the supplier, not the spender" idea Eisman has been pushing all year, arrived at from the chart rather than the thesis.
State Street is a custody and asset-management firm — it safeguards institutional portfolios and runs index funds. It sits in the group Verrone points to as evidence for the episode's biggest structural claim: after fifteen years in which money flowed relentlessly from active managers to cheap passive funds, the traditional asset managers are "breaking out for the first time in years."
Why that matters beyond the sector: if 2026 is "about the E, not the P/E" — earnings doing the work while valuations shrink — then differences between companies start mattering more than the direction of the whole index. Strategas calls that an "alpha market," and the asset-manager charts are their evidence that the market is starting to believe it.
T. Rowe Price is a classic active manager — it charges a fee to pick stocks, the business model most damaged by the passive era. Eisman asks the direct question ("are traditional money management stocks outperforming PE stocks?") and Verrone answers with the group, T. Rowe included.
The logic is simple: the value of stock-picking rises when stocks stop moving together. Owning the manager is a way to own that shift without having to pick the stocks yourself.
Invesco is the third name in the same breakout — another fee-based manager whose share price has been a casualty of money leaving active funds. Its improving chart is treated as confirmation rather than as a standalone recommendation.
"Ben's been a great chart," said immediately after the State Street / T. Rowe / Invesco list. Franklin Resources trades under the ticker BEN and is exactly that kind of traditional manager, which is why it is recorded here — but note that the transcript never says the company's name, so this is an inference from context, not a quotation.
The underlying claim is the same one running through the whole asset-management segment: these businesses have been structurally out of favour since quantitative easing began, and their charts are turning at the same time as the market's character.
Morgan Stanley is one of the two big US investment banks Verrone singles out among "the brokers [that] have been excellent here." What makes the observation strong is its breadth: not just the American names, but Japanese and European banks too — "every bank stock around the world is at new highs."
Two supports underneath it. First, the credit data refuses to confirm the private-credit scare: publicly traded corporate credit "remains very benign," and double-B spreads — the extra yield demanded on lower-quality corporate bonds, a reliable early-warning gauge — made new lows for this cycle. Second, Strategas' Washington analyst argues the US is in "an extreme period of financial deregulation," on the reasoning that the Fed cannot shrink its own balance sheet until the banks are freed to hold more of the plumbing themselves.
Verrone's own honest caveat: a world where every bank is at a high is not what the eve of a credit crisis usually looks like — "it seems a little out of step" with the worry.
Named beside Morgan Stanley as leadership within a globally strong bank tape. Trennert supplies the fundamental case rather than the chart: he expects the yield curve to steepen (banks borrow short and lend long, so a steeper curve widens their margin), the economy is strong enough that "credit losses should be pretty minimal," and deregulation is a tailwind.
His structural aside is worth keeping: private credit grew as "largely a regulatory arb" — post-crisis rules pushed lending out of banks, and private funds stepped into the gap. If that cycle turns, the damage lands outside the banking system, "so it won't be that systemic" — but it will be concentrated on the wealthy investors who own it.
Thermo Fisher sells the instruments, reagents and lab services that pharmaceutical and biotech research runs on — the picks-and-shovels of drug discovery. It has been out of favour for years as biotech funding dried up and pharma cut research spending.
Verrone's call is a bottoming call made from price, not earnings: these "left for dead" life-science names "haven't been looked at in years," and the reversals in them are "particularly notable" — his phrase for a chart that turns after nobody is left to sell. He ranks health care first among defensive sectors on this basis.
Danaher is Thermo Fisher's closest analogue — a group of life-science and diagnostics businesses selling tools and consumables to labs. Same story, same charts, same verdict: a major bottom after years of neglect.
The transferable observation is that a sector where the fundamental news has been uniformly poor for years, and where the stocks stop going down anyway, is telling you the selling is finished.
Illumina makes DNA-sequencing machines and the consumables they consume — the most cyclical of the three life-science names, because a sequencer is a capital purchase a squeezed research budget can simply defer.
That is precisely why Verrone flags it: the deepest de-rating produces the sharpest reversal when funding conditions stop deteriorating. He calls it a "major major bottom," a phrase he uses sparingly.
UnitedHealth is the largest US health insurer. It came up when Eisman asked about health insurance specifically, and Verrone's answer is unusual in a market conversation: an admission of error. The group put in major lows late last year and early this year, and he missed them because "I got too dogmatic on those."
The lesson embedded in it is the useful part. A view held for good reasons becomes a liability once the price has already discounted it; his own discipline — "we try not to do that" — is to let the tape retire a thesis rather than defending it. He is constructive on the group now but says the actual leadership is in pharma and biotech, not managed care.
Trennert's counterweight applies to the whole sector: politics in the US is "increasingly getting populist," there is "a reaction against big anything," and where government sets prices "it's going the other way." Government expansion helped these companies for years; it now works against them.
Cigna is the other big managed-care name in the same call — insurance plus a very large pharmacy-benefit business that sits between drug makers and employers. It is grouped with UnitedHealth as having "put major lows in late last year early this year."
Same caveat as UNH: bottomed, yes; the leadership, no. And the same political overhang, since the pharmacy-benefit business is precisely the middleman role populist politics of both parties keeps targeting.
Kraft Heinz is packaged food — the archetype of a "defensive" stock that is supposed to hold up when the economy weakens, and which has instead been savaged for two years as shoppers traded down and weight-loss drugs cut into snack volumes.
Verrone's call is deliberately small: "starting to bottom here… worth a look," immediately followed by "I would hardly call the sector leader in the market." Staples remain last in his defensive ranking. This is a bombed-out group showing its first signs of life, not a rotation call.
Hershey has had the additional problem of cocoa costs on top of the general staples malaise. It is named beside Kraft Heinz as one of the names "starting to bottom," with exactly the same modest framing — worth a look, not leadership.
Schneider Electric is the French supplier of electrical distribution and energy-management equipment — switchgear, power management, data-centre cooling. It is the European equivalent of the American AI build-out names.
Verrone raises it to make an uncomfortable point about European diversification. The Euro Stoxx is at a record high, but not because Europe is recovering: autos and luxury, its two China-dependent industries, are in multi-year bear markets, and the index's new high comes from Schneider, Siemens Energy and the banks. Buying Europe to get away from the AI trade mostly buys you the AI trade in euros.
Siemens Energy makes gas and steam turbines and grid equipment — the machinery that turns fuel into the electricity a data centre consumes. Named as the second engine of Europe's index high.
It is the same structure as Eisman's own GE Vernova position: when demand for electricity outruns supply, the surest earnings are at the company selling the generating equipment, not at the company selling the power or the one buying it. That last distinction matters in this episode, because the unregulated US power producers are the sector Verrone is negative on.
Amazon appears three times, and the three appearances are the episode's argument in miniature. As a business, its cloud arm is one of the five hyperscalers building AI capacity. As an accounting object, its free cash flow — cash left after capital spending — was negative over the trailing twelve months, because the capital spending is enormous. As a stock, it just made new highs.
Trennert's client heard "the most bullish conference call in my life," and Trennert's reply is the honest version of the bull case: the demand is real, "but I don't see how you do it without hitting the bond and equity markets… it's not going to come out of cash flow." That is not a bearish call on the business. It is a statement about who funds the build — increasingly bondholders and new shareholders rather than the company's own earnings, which dilutes the existing owner.
Verrone's contribution is the reminder that the market has already absorbed a version of this: the name fell hard from mid-May and has since recovered to new highs. Net positive, with the funding question unresolved.
Microsoft is the best-placed of the hyperscalers on both measures used in this conversation, which is what makes its numbers sobering. Its quarterly cash flow of roughly $19bn was "the best of anybody" — and still down about 25% from a year earlier. The whole group is converting a smaller and smaller share of its revenue into cash it can hand to shareholders.
On the tape it is the strongest of the lot: its best five-day advance since the company came public, which Verrone reads as evidence that the negativity three weeks earlier had overshot rather than as proof of anything fundamental.
It also plays the historical role in the antitrust segment. Microsoft spent the late 1990s in court, "won" in the same sense IBM did, and the cost was the attention of its management during a technology transition.
Alphabet is the name at the centre of the episode's most human story. Strategas published a sentence — "it's going to be hard to continue to grow AI investments without further dilution of shareholders" — and a client fired Trennert personally over it.
"Dilution" simply means issuing new shares: each existing shareholder ends up owning a smaller slice of the same company. Alphabet raised $85bn of equity, and the reason that is startling is history — a company that has thrown off cash since the early 2000s has not needed to ask shareholders for money since then. The AI build-out has turned a cash machine into a business that taps the capital markets.
Against that, Verrone notes the stock is "basically back at the highs." The net stance here is genuinely mixed, and Trennert says so explicitly: the dilution worry is real, he expects the spending to continue, and "I wouldn't short it." He is market-weight technology — neither over- nor under-owning it relative to the index.
Oracle is the most leveraged expression of the AI build-out among the big names — it is borrowing heavily to build capacity it has already contracted out, and it was "just downgraded," meaning a ratings agency judged its debt riskier than before.
Verrone uses the same stock for the opposite purpose. When sentiment toward the hyperscalers "reached a fever pitch of negativity" a few weeks earlier, Oracle at around $120 was the marker of the extreme. His framework treats that as an emotional low rather than a fundamental verdict — the point at which the marginal seller has finished selling.
Both readings can be true, which is why this lands neutral: the balance sheet is the most stretched in the group, and the price already reflects a great deal of that.
Eisman's own analysis, and the clearest negative in the episode. Revenue grew 28% — genuinely strong — while expenses grew 55%, so profits went backwards. He points out there is no sign of that reversing, because the spending is committed.
The detail he singles out is depreciation, and it is worth understanding. When a company buys chips and builds data centres, the cost doesn't hit profits all at once; it is spread over the assets' useful life as an annual depreciation charge. Meta's has gone from roughly $4bn to $6bn and, on his arithmetic, heads to $8bn, $10bn, $12bn as more capacity comes online. That charge arrives every year whether or not the AI investment works — "it's like a weight on your shoulders." Quarterly cash flow of $785m at a company of Meta's size is the same fact seen from the cash side.
Layered on top is the legal overhang: hundreds of lawsuits alleging the algorithms harm users' mental health, two already decided against the company. Individually the sums are trivial against Meta's revenue. The precedent that matters is IBM's — the company won its antitrust case and still lost, because twelve years of litigation consumed the management attention that should have gone into the next platform.
Verrone declines to take a fundamental view and respects only the price: the stock fell 10-12% on the results and recovered the entire loss within three days, which he says he has to acknowledge whatever the income statement says.
Anthropic is one of the two large private AI labs whose spending on cloud computing is the demand underneath the hyperscalers' AI revenue. The striking thing about this segment is that Trennert reaches the same map Eisman built independently three days earlier on the Weekly Wrap.
His version: the hyperscalers have real businesses with real moats, just capital-intensive ones. The labs are "where it's most questionable" — they burn cash, they have Chinese competitors, and roughly 70% of the hyperscalers' AI revenue comes from these two customers. That is a concentration hiding underneath the market's visible concentration: the S&P's top ten are 39% of the index, those companies' AI growth depends on five buyers, and two of those buyers fund themselves by raising capital.
The conclusion is conditional, not predictive: "if Open AI and Anthropic ever get in trouble, the ecosystem is in trouble." Eisman's response — "I think it's undeniable" — is agreement about the structure, not a forecast of the event.
The other half of the same dependency, and the same characterisation: heavily negative cash flow, funded by capital raises, facing cheaper Chinese competition, and jointly responsible for about 70% of hyperscaler AI revenue.
What makes this worth recording is the corroboration. Two strategists who cover the entire market, with no stake in Eisman's thesis, arrived at the same single point of failure from their own client work. When independent analyses converge on the same node, the node is real even if the timing is unknowable.
Constellation is an unregulated power producer — it owns generation (a great deal of it nuclear) and sells electricity at market prices rather than at rates a regulator sets. In a world of exploding data-centre electricity demand, this is supposed to be the ideal business, and for two years it traded like it.
Verrone's observation is that it has stopped working, and that is the episode's most useful negative precisely because it contradicts the obvious thesis. Regulated utilities have traded badly all year and are making new lows; now the unregulated producers "have also started to weaken." Trennert's explanation is political rather than economic: as data centres bid up power prices, voters notice their own bills, and "the politics are starting to consume the utility sector."
The transferable rule: when the names that should be great in an environment start underperforming anyway, something outside the fundamentals is setting the price — here, the risk that the profits get regulated or taxed away.
Talen is the smaller merchant power producer in the same trio, best known for co-locating data centres directly next to its nuclear generation — the purest expression of the AI-power trade available in public markets.
Named with Constellation and Vistra as also weakening. The read-through is that the market is repricing the entire category, not questioning one company's contracts.
Vistra is the third unregulated generator flagged as rolling over. Placed against the same episode's positive stance on the build-out contractors — Quanta, EMCOR, Caterpillar, Schneider, Siemens Energy — it sharpens a distinction worth carrying forward.
The companies that sell equipment and construction into the AI power build are getting paid on contracts and backlogs. The companies that own the generation are getting paid on a politically visible price. When populism runs against "big anything," the second group carries a risk the first does not.
Notes compiled from the public YouTube video (The Real Eisman Playbook, Ep 73, recorded early August 2026, published 2026-08-17) and the saved transcript. Views are Jason Trennert's, Chris Verrone's (both Strategas) and Steve Eisman's as expressed in this episode, attributed by name. For personal study — not investment advice.